Author

Pelin Kaya

University of LuxembourgORCID 0000-0003-4735-4116Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexandros KiriazisiD· 1 shared Anthoula GaigneauxiD· 1 shared Daniel AbankwaiD· 1 shared Elisabeth Schaffner‐ReckingeriD· 1 shared Enrico GlaabiD· 1 shared Ganesh babu ManoharaniD· 1 shared Karolina PaviciD· 1 shared Maria Burgos Renedo· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Alexandros KiriazisORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistryJournal of Medicinal ChemistryPeer-reviewedMay 17, 2024

An improved PDE6D inhibitor combines with Sildenafil to synergistically inhibit KRAS mutant cancer cell growth

Pelin Kaya, Elisabeth Schaffner‐Reckinger, Ganesh babu Manoharan…·Daniel Abankwa

The paper develops a novel PDE6D inhibitor, Deltaflexin3, which synergizes with Sildenafil to inhibit KRAS mutant cancer cell growth, though survival data suggest further exploration of K-Ras and PDE6D interplay.

24 citations

humanproteomics

𝕏 PostBluesky